Probiotics prevent enterohaemorrhagic Escherichia coli O157 : H7-mediated inhibition of interferon-γ-induced tyrosine phosphorylation of STAT-1

Microbiology

Volumn 155, Issue 2, 2009, Pages 531-540

  Jandu, Narveen ^a   Zeng, Zoe Jingjing ^a   Johnson Henry, Kathene C ^a   Sherman, Philip M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROBIOTIC AGENT; STAT1 PROTEIN; BACTERIAL PROTEIN; TYROSINE;

ARTICLE; BACTERIAL STRAIN; CELL VIABILITY; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EPITHELIUM CELL; ESCHERICHIA COLI O157; GENE ACTIVATION; GENE DISRUPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INNATE IMMUNITY; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CELL LINE; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; ESCHERICHIA COLI INFECTION; METABOLISM; MICROBIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ESCHERICHIA COLI; LACTOBACILLUS HELVETICUS; LACTOBACILLUS RHAMNOSUS;

BACTERIAL PROTEINS; CELL LINE; DOWN-REGULATION; EPITHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; INTERFERON-GAMMA; LACTOBACILLUS HELVETICUS; PHOSPHORYLATION; PROBIOTICS; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TYROSINE;

EID: 62249173000     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.021931-0     Document Type: Article

References (39)

1. Baran-Marszak, F., Feuillard, J., Najjar, I., Le Clorennec, C., Bechet, J. M., Dusanter-Fourt, I., Bornkamm, G. W., Raphael, M. & Fagard, R. (2004). Differential roles of STAT1α and STAT1β in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 104, 2475-2483.
2. Bhavsar, A. P., Guttman, J. A. & Finlay, B. B. (2007). Manipulation of host-cell pathways by bacterial pathogens. Nature 449, 827-834.
3. Blackall, D. P. & Marques, M. B. (2004). Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation. Am J Clin Pathol 121 (Suppl.), S81-S88.
4. Boirivant, M. & Strober, W. (2007). The mechanism of action of probiotics. Curr Opin Gastroenterol 23, 679-692.
5. Bry, L. & Brenner, M. B. (2004). Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J Immunol 172, 433-441.
6. Ceponis, P. J., McKay, D. M., Ching, J. C., Pereira, P. & Sherman, P. M. (2003). Enterohemorrhagic Escherichia coli O157 :H7 disrupts Stat1-mediated gamma interferon signal transduction in epithelial cells. Infect Immun 71, 1396-1404.
7. Corr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C. & Gahan, C. G. (2007). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci U S A 104, 7617-7621.
8. Eutamene, H. & Bueno, L. (2007). Role of probiotics in correcting abnormalities of colonic flora induced by stress. Gut 56, 1495-1497.
9. Fedorak, R. N. & Madsen, K. L. (2004). Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20, 146-155.
10. Frick, J. S., Fink, K., Kahl, F., Niemiec, M. J., Quitadamo, M., Schenk, K. & Autenrieth, I. B. (2007). Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect Immun 75, 3490-3497.
11. Gill, H. S., Shu, Q., Lin, H., Rutherfurd, K. J. & Cross, M. L. (2001). Protection against translocating Salmonella typhimurium infection in mice by feeding the immuno-enhancing probiotic Lactobacillus rhamnosus strain HN001. Med Microbiol Immunol 190, 97-104.
12. Higgins, L. M., Frankel, G., Douce, G., Dougan, G. & MacDonald, T. T. (1999). Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun 67, 3031-3039.
13. Jandu, N., Ceponis, P. J., Kato, S., Riff, J. D., McKay, D. M. & Sherman, P. M. (2006). Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon. Infect Immun 74, 1809-1818.
14. Jandu, N., Shen, S., Wickham, M. E., Prajapati, R., Finlay, B. B., Karmali, M. A. & Sherman, P. M. (2007). Multiple seropathotypes of verotoxin-producing Escherichia coli (VTEC) disrupt interferon-γ-induced tyrosine phosphorylation of signal transducer and activator of transcription (Stat)-1. Microb Pathog 42, 62-71.
15. Johnson-Henry, K. C., Nadjafi, M., Avitzur, Y., Mitchell, D. J., Ngan, B. Y., Galindo-Mata, E., Jones, N. L. & Sherman, P. M. (2005). Amelioration of the effects of Citrobacter rodentium infection in mice by pretreatment with probiotics. J Infect Dis 191, 2106-2117.
16. Johnson-Henry, K. C., Hagen, K. E., Gordonpour, M., Tompkins, T. A. & Sherman, P. M. (2007). Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell Microbiol 9, 356-367.
17. Kaper, J. B., Nataro, J. P. & Mobley, H. L. (2004). Pathogenic Escherichia coli. Nat Rev Microbiol 2, 123-140.
18. Karch, H., Tarr, P. I. & Bielaszewska, M. (2005). Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295, 405-418.
19. Karmali, M. A., Petric, M., Lim, C., Fleming, P. C., Arbus, G. S. & Lior, H. (1985). The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151, 775-782.
20. Mack, D. R., Ahrne, S., Hyde, L., Wei, S. & Hollingsworth, M. A. (2003). Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 52, 827-833.
21. Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L. & De Simone, C. (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580-591.
22. Maki, D. G. (2006). Don't eat the spinach - controlling foodborne infectious disease. N Engl J Med 355, 1952-1955.
23. Mundy, R., Girard, F., FitzGerald, A. J. & Frankel, G. (2006). Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol Lett 265, 126-132.
24. Naser, S. M., Hagen, K. E., Vancanneyt, M., Cleenwerck, I., Swings, J. & Tompkins, T. A. (2006). Lactobacillus suntoryeus Cachat and Priest 2005 is a later synonym of Lactobacillus helveticus (Orla-Jensen 1919) Bergey et al. 1925 (Approved Lists 1980). Int J Syst Evol Microbiol 56, 355-360.
25. Norman, G. R. & Streiner, D. L. (2003). PDQ Statistics, 3rd edn. Hamilton, ON: B. C. Decker.
26. O'Hara, A. M., O'Regan, P., Fanning, A., O'Mahony, C., Macsharry, J., Lyons, A., Bienenstock, J., O'Mahony, L. & Shanahan, F. (2006). Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118, 202-215.
27. Rangel, J. M., Sparling, P. H., Crowe, C., Griffin, P. M. & Swerdlow, D. L. (2005). Epidemiology of Escherichia coli O157 :H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11, 603-609.
28. Resta-Lenert, S. & Barrett, K. E. (2003). Live probiotics protect intestinal epithelial cells from the effects of infection with entero-invasive Escherichia coli (EIEC). Gut 52, 988-997.
29. Resta-Lenert, S. & Barrett, K. E. (2006). Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130, 731-746.
30. Senok, A. C., Ismaeel, A. Y. & Botta, G. A. (2005). Probiotics: facts and myths. Clin Microbiol Infect 11, 958-966.
31. Serna, A., 4th & Boedeker, E. C. (2008). Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr Opin Gastroenterol 24, 38-47.
32. Servin, A. L. (2004). Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28, 405-440.
33. Sherman, P. M., Johnson-Henry, K. C., Yeung, H. P., Ngo, P. S., Goulet, J. & Tompkins, T. A. (2005). Probiotics reduce enterohemorrhagic Escherichia coli O157 : H7- and enteropathogenic E. coli O127 : H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 73, 5183-5188.
34. Shtrichman, R. & Samuel, C. E. (2001). The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 4, 251-259.
35. Silva, A. M., Barbosa, F. H., Duarte, R., Vieira, L. Q., Arantes, R. M. & Nicoli, J. R. (2004). Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice. J Appl Microbiol 97, 29-37.
36. Simmons, C. P., Goncalves, N. S., Ghaem-Maghami, M., Bajaj-Elliott, M., Clare, S., Neves, B., Frankel, G., Dougan, G. & MacDonald, T. T. (2002). Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-γ. J Immunol 168, 1804-1812.
37. + T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun 71, 5077-5086.
38. Tarr, P. I., Gordon, C. A. & Chandler, W. L. (2005). Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-1086.
39. Tien, M. T., Girardin, S. E., Regnault, B., Le Bourhis, L., Dillies, M. A., Coppee, J. Y., Bourdet-Sicard, R., Sansonetti, P. J. & Pedron, T. (2006). Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol 176, 1228-1237.